Long-term stabilized formulations

   
   

A stable G-CSF formulation having a residual ratio of G-CSF of 90% or more after long-term storage testing at 25 C. for 3 months or a residual ratio of G-CSF of 90% or more after long-term storage testing at 40 C. for 2 months or a residual ratio of G-CSF of 90% or more after accelerated testing at 50 C. for 1 month or a residual ratio of G-CSF of 90% or more after accelerated testing at 60 C. for 2 weeks and a content of Met-oxidized G-CSF of 1% or less after accelerated testing at 50 C. for 1 month or after accelerated testing at 60 C. for 2 weeks.

 
Web www.patentalert.com

< Substituted amides, sulfonamides and ureas useful for inhibiting kinase activity

< Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides

> Composition, methods and reagents for the synthesis of a soluble form of human PHEX

> Therapeutic dry powder preparation

~ 00189